TUG1 and hepatoblastoma: The new vessels provide the main routes by which tumor cells exit the primary tumor site and enter the circulation.17 Here, we show that lncRNA-TUG1 knockdown inhibits tumor growth and tumor angiogenesis in vivo, and reduces hepatoblastoma cell viability, proliferation, invasion, and migration in vitro.